OTCMKTS:PHCEF Pharmacielo (PHCEF) Stock Price, News & Analysis $0.03 0.00 (-8.42%) As of 05/9/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Pharmacielo Stock (OTCMKTS:PHCEF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Pharmacielo alerts:Sign Up Key Stats Today's Range$0.03▼$0.0450-Day Range$0.03▼$0.0652-Week Range$1.90▼$9.98Volume859 shsAverage Volume64,155 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPharmaCielo Ltd., through its subsidiary, PharmaCielo Colombia Holdings S.A.S., cultivates, processes, produces, and supplies medicinal-grade cannabis oil extracts and related products in Colombia and internationally. It provides cannabidiol and tetrahydrocannabinol-focused cannabis oil extracts for channel distributors, including pharmacies, medical clinics, and cosmetic companies. The company was formerly known as Pan American Cannabis Inc. and changed its name to PharmaCielo Ltd. in September 2014. PharmaCielo Ltd. is headquartered in Toronto, Canada.Read More… Receive PHCEF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharmacielo and its competitors with MarketBeat's FREE daily newsletter. Email Address PHCEF Stock News HeadlinesClosing Bell: Pharmacielo Ltd down on Monday (PCLO)July 29, 2024 | theglobeandmail.comPharmaCielo Ltd. (PCLO.V)November 20, 2023 | finance.yahoo.comShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is about to announce could change the AI market once again. Experts already predict the total addressable market could climb past $20 trillion. But Sykes believes most investors have missed what’s coming next. He’s tracking a new shift — and says the biggest gains are still ahead.May 14, 2025 | Timothy Sykes (Ad)PharmaCielo Ltd Ordinary SharesNovember 12, 2023 | morningstar.comClosing Bell: Pharmacielo Ltd down on Friday (PCLO)October 21, 2023 | theglobeandmail.comClosing Bell: Pharmacielo Ltd down on Wednesday (PCLO)September 14, 2023 | theglobeandmail.comClosing Bell: Pharmacielo Ltd up on Friday (PCLO)September 9, 2023 | theglobeandmail.comClosing Bell: Pharmacielo Ltd up on Tuesday (PCLO)June 7, 2023 | theglobeandmail.comSee More Headlines PHCEF Stock Analysis - Frequently Asked Questions How have PHCEF shares performed this year? Pharmacielo's stock was trading at $0.0576 at the start of the year. Since then, PHCEF stock has decreased by 39.6% and is now trading at $0.0348. View the best growth stocks for 2025 here. How do I buy shares of Pharmacielo? Shares of PHCEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:PHCEF CIKN/A Webwww.pharmacielo.com Phone647-560-4640FaxN/AEmployees49Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:PHCEF) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s third-term comments grabbed headlines, but the bigger story is what he’s planning next. A new report ...Porter & Company | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredMAY 14: New IPO 350X Bigger Than Amazon IPO?The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, Ma...Paradigm Press | SponsoredBitcoin Just Broke $100K – Are You Positioned?This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA New Economic Shift – How You Can PrepareWhile everyone's focused on the Fed and interest rates... most investors are missing the real story. There'...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharmacielo Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharmacielo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.